Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02735577 · ClinicalTrials.gov registry record · Phase 4
Neural Mechanisms of Disulfiram Effects
A Phase 4 study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 7
- Enrollment target
NCT02735577 is a Phase 4 study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 7 participants.
The verdict
NCT02735577, a Phase 4 study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 7 participants
- Enrollment target
Study Summary
This study combines functional MRI with medication treatment in order to understand the neural mechanisms by which disulfiram, a currently approved medication for alcohol use disorder, changes behavior. Disulfiram is a medication that prevents drinking by causing a highly unpleasant physical reaction when alcohol is consumed while it is being taken. Thus, it provides a means for studying the general neural mechanisms by which awareness of risks impacts behavior change in alcohol use disorder.
Interventions
- DRUG Disulfiram
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2016-03 |
| Est. Completion | 2020-10-16 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02735577
The ClinicalTrials.gov registry entry for NCT02735577 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Disulfiram is the first listed.
NCT02735577 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02735577 about?
NCT02735577 is a clinical study titled "Neural Mechanisms of Disulfiram Effects". This study combines functional MRI with medication treatment in order to understand the neural mechanisms by which disulfiram, a currently approved medication for alcohol use disorder, changes behavior. Disulfiram is a medication that prevents drinking by causing a highly unpleasant physical reactio...
What is the current status of trial NCT02735577?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 7 participants. The study started on 2016-03. Estimated completion is 2020-10-16.
What interventions are being tested in trial NCT02735577?
The interventions under investigation include: Disulfiram (DRUG).
Who is sponsoring clinical trial NCT02735577?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.